Coverage
-
January 29, 2020
A New York federal judge has given pharmaceutical firm Takeda permission to appeal to the Second Circuit two decisions that preserved allegations it delayed the entry of generic alternatives to diabetes treatment Actos.
5 other articles on this case.
View all »